Answers are grounded in this paper and cite their sources.
of findings for the main comparison. Prospective genetic HLA-B*57:01 screening compared with standard care for drug-induced skin rash Patient or population: patients with HIV-1 infection and a pre-established clinical need for treatment with an antiretroviral drug regimen containing abacavir but with an unknown HLA-B*57:01 status.
No takes yet. Share an insight, caveat, or question.
Alfirevic et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: